{
    "clinical_study": {
        "@rank": "142861", 
        "acronym": "EC-02", 
        "arm_group": [
            {
                "arm_group_label": "Total Hysterectomy (TH)", 
                "arm_group_type": "Experimental", 
                "description": "Patients may receive total hysterectomy (TH) and bilateral pelvic and para-aortic lymph node dissection (BPLND)."
            }, 
            {
                "arm_group_label": "TH and bilateral salpingo-oophorectomy (TH/BSO)", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients may receive total hysterectomy, bilateral salpingo-oophorectomy (BSO) and bilateral pelvic and para-aortic lymph node dissection."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized trial is studying the efficacy and safety of the hysterectomy alone compared\n      with hysterectomy and bilateral salpingo-oophorectomy (BSO) for patients with Stage IA\n      endometrial carcinoma."
        }, 
        "brief_title": "The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Endometrial Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Carcinoma", 
                "Endometrial Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  FIGO stage: \u2160A, endometrial carcinoma;\n\n          -  Female, Chinese women;\n\n          -  premenopausal women\uff1b\n\n          -  \u2264 50 years old;\n\n          -  Pathological diagnosis by curettage/hysteroscopy : G1\n\n          -  No prior treatment;\n\n          -  Provide written informed consent.\n\n        Exclusion Criteria:\n\n          -  The suspicious metastasis of ovarian;\n\n          -  Family history of ovarian cancer;\n\n          -  Suffering from other malignancies;\n\n          -  Concurrently participating in other clinical trials;\n\n          -  Unable or unwilling to sign informed consents;\n\n          -  Unable or unwilling to abide by protocol."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820884", 
            "org_study_id": "2012-GYN/EC-02"
        }, 
        "intervention": [
            {
                "arm_group_label": "Total Hysterectomy (TH)", 
                "description": "Total hysterectomy", 
                "intervention_name": "TH", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "TH and bilateral salpingo-oophorectomy (TH/BSO)", 
                "description": "Total hysterectomy and bilateral salpingo-oophorectomy", 
                "intervention_name": "TH/BSO", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Total Hysterectomy (TH)", 
                    "TH and bilateral salpingo-oophorectomy (TH/BSO)"
                ], 
                "description": "bilateral pelvic and para-aortic lymph node dissection", 
                "intervention_name": "BPLND", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 26, 2013", 
        "location": [
            {
                "contact": {
                    "email": "weng.dh@gmail.com", 
                    "last_name": "Danhui Weng, MD", 
                    "phone": "+862783662681"
                }, 
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430030"
                    }, 
                    "name": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"
                }, 
                "investigator": {
                    "last_name": "Changyu Wang, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "xingshengyang@yahoo.com", 
                    "last_name": "Xingsheng Yang, MD, Ph D", 
                    "phone": "13791123129"
                }, 
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "250012"
                    }, 
                    "name": "Qilu Hospital\uff0cShandong University"
                }, 
                "investigator": {
                    "last_name": "Xingsheng Yang, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "maoyy3@yahoo.com.cn", 
                    "last_name": "Yuyan Mao, MD", 
                    "phone": "13989816955"
                }, 
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "310006"
                    }, 
                    "name": "Women's Hospital, School of Medicine, Zhejiang University"
                }, 
                "investigator": {
                    "last_name": "Yuyan Mao, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma: A Multicenter, Prospective, Randomized Trial", 
        "overall_contact": {
            "email": "weng.dh@gmail.com", 
            "last_name": "Danhui Weng, MD, PhD", 
            "phone": "+862783662681"
        }, 
        "overall_official": {
            "affiliation": "Shandong University", 
            "last_name": "Beihua Kong, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Disease-free survival (DFS)", 
            "safety_issue": "No", 
            "time_frame": "3-year DFS"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820884"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Huazhong University of Science and Technology", 
            "investigator_full_name": "Ding Ma", 
            "investigator_title": "Director of the department of Obstetrics and Gynecology, Tongji Hospital", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "To observe the level of female hormone\uff0ci.e., estrogen, FSH, LH", 
                "measure": "Clinical gynecologic endocrine function", 
                "safety_issue": "No", 
                "time_frame": "1-year period"
            }, 
            {
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "3-year period"
            }, 
            {
                "measure": "Overall Survival (OS)", 
                "safety_issue": "No", 
                "time_frame": "3-year OS"
            }
        ], 
        "source": "Huazhong University of Science and Technology", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Shandong University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Huazhong University of Science and Technology", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Zhejiang University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Ding Ma", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}